From HealthcareDive
Dive Brief:
- Teladoc expects to bring in $2.03 billion in revenue in 2021, according to a preliminary filing with the U.S Securities and Exchange Commission, substantially above the high point of the telehealth giant’s previous guidance and almost doubling 2020’s topline.
- The vendor conducted an estimated 14.7 million visits in the 2021 fiscal year, CEO Jason Gorevic said Monday at J.P. Morgan’s annual investor conference. That’s again above the high end of its guidance, and up from 10.6 million visits in 2020.
- Despite the company’s performance, investors have been leery amid worries that demand for virtual care will drop off as COVID-19 cases do. Teladoc’s stock, which has been on a steady downward trajectory this year, ticked up slightly over Monday’s trade following Teladoc’s JPM presentation.